An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects with Intermediate Age-Related Macular Degeneration

Administered By

Ophthalmology, Vitreoretinal Diseases & Surgery

Contributors

Cousins, Scott William Principal Investigator
Mettu, Priyatham S Core PI

Start/End

September 1, 2016 - August 31, 2021